Diana J. Wilkie|Robert E. Molokie|Debra Boyd-Seal|Marie L. Suarez|Young Ok Kim|Shiping Zong|H. Wittert|Zhongsheng Zhao|Yogen Saunthararajah|Zaijie J. Wang
Patient-Reported Outcomes: Descriptors of Nociceptive and Neuropathic Pain and Barriers to Effective Pain Management in Adult Outpatients With Sickle Cell Disease
University of Illinois at Chicago|Jesse Brown VA Medical Center|University of Illinois at Chicago|University of Illinois at Chicago|University of Illinois at Chicago|University of Illinois at Chicago|University of Illinois at Chicago|University of Illinois at Chicago|University of Illinois at Chicago|University of Illinois at Chicago|Cleveland Clinic|University of Illinois at Chicago
despite frequent episodes severe recurrent pain sickle cell disease scd sensory pain outpatient adults scd lacks sufficient characterization furthermore pivotal barriers may interfere patients adherence prescribed analgesic therapies studied systematically describe sensory pain characteristics barriers analgesic use reported adults scd routine clinic visits patients n 145 67 female 94 african american completed measures pentablet computer patients reported average 36 23 pain sites mean current pain intensity 33 32 least 30 27 worst 49 35 pain intensity 24 hours 0 10 scale multiple neuropathic 45 34 83 selected none nociceptive 68 40 pain descriptors continuous pain pattern 59 mean pain barriers score 22 09 33 dissatisfied pain levels 14 reported taking least 1 adjuvant drug 82 taking nonopioids 85 step 2 opioids 65 step 3 opioids patients reported using average 49 27 analgesics pain barriers scores similar greater people cancer importantly pain may nociceptive neuropathic contrary common expectations scd pain nociceptive patients however took drugs effective neuropathic pain